Mindset Pharma (MSSTF) Stock Price, News & Analysis

Company Overview

Mindset Pharma is a clinical‐stage biopharmaceutical company dedicated to the discovery and development of novel psychedelic‐inspired small molecules for the treatment of neurological and psychiatric disorders. By leveraging advanced medicinal chemistry and structure‐based drug design, the company seeks to optimize naturally occurring psychoactive compounds for improved safety, selectivity and pharmacokinetic properties. Mindset’s preclinical and early clinical assets are focused on conditions such as post‐traumatic stress disorder, major depressive disorder and cluster headache.

The company’s proprietary chemistry platform enables the systematic generation and evaluation of psilocybin analogs, mescaline derivatives and other psychoactive scaffolds. Integrating computational modeling, in vitro pharmacology and in vivo studies, Mindset refines lead candidates to enhance blood–brain barrier penetration, metabolic stability and receptor binding profiles. This iterative approach aims to deliver differentiated therapeutics that offer once‐daily dosing, reduced psychoactivity and an improved side‐effect profile compared to native psychedelics.

Founded in 2018 and headquartered in Montreal, Canada, Mindset Pharma conducts its research and development activities both domestically and through collaborative partnerships in North America. The company is guided by an experienced leadership team with deep expertise in neuropsychopharmacology, drug discovery and regulatory strategy. Supported by alliances with academic institutions and industry stakeholders, Mindset is advancing its pipeline toward clinical proof-of-concept studies, with the goal of bringing new treatment options to patients with unmet needs in central nervous system disorders.

Key Stats

• Today's Range: $0.54 to $0.54
• 50-Day Range: $0.54 to $0.54
• 52-Week Range: $0.16 to $0.56
• Volume: N/A
• Average Volume: 33,313 shs
• Market Capitalization: N/A
• P/E Ratio: N/A
• Dividend Yield: N/A
• Price Target: N/A
• Consensus Rating: N/A

MSSTF Stock Analysis - Frequently Asked Questions

How have MSSTF shares performed this year?

Mindset Pharma's stock was trading at $0.5381 at the beginning of the year. Since then, MSSTF stock has increased by 0.0% and is now trading at $0.5381.

How do I buy shares of Mindset Pharma?

Shares of MSSTF stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Industry, Sector and Symbol

• Stock Exchange: OTCMKTS
• Sector: Medical
• Industry: Biotechnology
• Sub-Industry: N/A
• Current Symbol: OTCMKTS:MSSTF
• CIK: N/A
• Web: www.mindsetpharma.com
• Phone: N/A
• Fax: N/A
• Employees: N/A
• Year Founded: N/A

Profitability

• EPS (Trailing Twelve Months): N/A
• Trailing P/E Ratio: N/A
• Forward P/E Ratio: N/A
• P/E Growth: N/A
• Net Income: N/A
• Net Margins: N/A
• Pretax Margin: N/A
• Return on Equity: N/A
• Return on Assets: N/A

Debt

• Debt-to-Equity Ratio: N/A
• Current Ratio: N/A
• Quick Ratio: N/A

Sales & Book Value

• Annual Sales: N/A
• Price / Sales: N/A
• Cash Flow: N/A
• Price / Cash Flow: N/A
• Book Value: N/A
• Price / Book: N/A

Miscellaneous

• Outstanding Shares: N/A
• Free Float: N/A
• Market Cap: N/A
• Optionable: Not Optionable
• Beta: N/A